Literature DB >> 6408222

Non-A, non-B hepatitis in persistent carriers of hepatitis B virus.

K N Tsiquaye, B Portmann, G Tovey, H Kessler, S Hu, X Z Lu, A J Zuckerman, J Craske, R Williams.   

Abstract

There are reports in the literature that infection with hepatitis A virus in hepatitis B carriers can result in resolution of the carrier state. In an attempt to induce clearance of the carrier state of hepatitis B virus in two persistently infected chimpanzees, the chimpanzees were infused with documented non-A, non-B infectious material. Biochemical and histopathological evidence of hepatitis was accompanied by the unique abnormalities of endoplasmic reticulum associated with non-A, non-B hepatitis in the chimpanzees. Elevation of alanine aminotransferase was accompanied by fourfold reduction in one chimpanzee and sixfold reduction in the other in the plasma levels of HBV-associated DNA polymerase activity and simultaneously by twofold reduction in the concentration of hepatitis B surface antigen in both chimpanzees. A mediator may account for these changes in markers of hepatitis B virus infection, and this mechanism may also explain the occurrence of spontaneous regression in some persistently infected carriers. The significance of transient red cell anaemia in non-A, non-B hepatitis, which was observed in one of the chimpanzees, is yet to be established.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408222     DOI: 10.1002/jmv.1890110302

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Acute delta superinfection in a previously unrecognised HBsAg carrier with transient loss of HBsAg simulating acute non-A, non-B hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

2.  Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation.

Authors:  E A Pariente; A Goudeau; F Dubois; C Degott; E Gluckman; A Devergie; C Brechot; C Schenmetzler; J Bernuau
Journal:  Dig Dis Sci       Date:  1988-09       Impact factor: 3.199

3.  Dissociation of alanine aminotransferase values in acute hepatitis A patients with and without past experience to the hepatitis B virus.

Authors:  A A Papachristou; A S Dumas; V C Katsouyannopoulos
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

4.  Causal Mediation Analysis of Survival Outcome with Multiple Mediators.

Authors:  Yen-Tsung Huang; Hwai-I Yang
Journal:  Epidemiology       Date:  2017-05       Impact factor: 4.822

5.  Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C.

Authors:  Yen-Tsung Huang; Chin-Lan Jen; Hwai-I Yang; Mei-Hsuan Lee; Jun Su; Sheng-Nan Lu; Uchenna H Iloeje; Chien-Jen Chen
Journal:  J Clin Oncol       Date:  2011-08-22       Impact factor: 44.544

6.  Permanent HBsAg clearance in chronic hepatitis B viral infection following acute delta superinfection.

Authors:  K P Chin; S Govindarajan; A G Redeker
Journal:  Dig Dis Sci       Date:  1988-07       Impact factor: 3.199

Review 7.  Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection.

Authors:  Yun-Fan Liaw
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells.

Authors:  C M Shih; S J Lo; T Miyamura; S Y Chen; Y H Lee
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.

Authors:  L T Mimms; J W Mosley; F B Hollinger; R D Aach; C E Stevens; M Cunningham; D V Vallari; L H Barbosa; G J Nemo
Journal:  BMJ       Date:  1993-10-30

10.  Mediation effect of hepatitis B and C on mortality.

Authors:  Yen-Tsung Huang; Joshua R Freeman; Hwai-I Yang; Jessica Liu; Mei-Hsuan Lee; Chien-Jen Chen
Journal:  Eur J Epidemiol       Date:  2016-01-20       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.